LA
TDAC

Linden Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Linden Advisors’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Buy
1,150,000
+550,000
+92% +$5.87M 0.06% 175
2026
Q1 		$6.34M Hold
600,000
– – 0.04% 253
2025
Q4 		$6.29M Hold
600,000
– – 0.04% 226
2025
Q3 		$6.21M Hold
600,000
– – 0.04% 201
2025
Q2 		$6.18M Hold
600,000
– – 0.04% 206
2025
Q1 		$6.05M Buy
+600,000
New +$6.03M 0.04% 180

Other funds holding TDAC

KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors's TDAC Position: Q2 2026 in Review

Linden Advisors increased its Translational Development Acquisition Corp (TDAC) stake by 92% in Q2 2026, buying an estimated $5.87M and bringing the position to 1,150,000 shares worth $12.3M. The position accounts for 0.06% of the portfolio, ranked #175.

Linden Advisors first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Linden Advisors held 1,150,000 shares of Translational Development Acquisition Corp worth $12.3M as of Q2 2026.
  • Linden Advisors bought 550,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $5.87M.
  • Translational Development Acquisition Corp made up 0.06% of Linden Advisors's portfolio in Q2 2026, its #175 holding.
  • Linden Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Linden Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.